Pearson expands Chief Technology Officer Dave Treat’s role to advance AI and digital strategy - April 2, 2025
Pearson has announced an expanded leadership role for Chief Technology Officer Dave Treat, who will now oversee the company’s digital and technology operations while continuing his existing responsibilities in architecture and innovation. The transition, effective April 7, follows the departure of Chief Information Officer Marykay Wells on… Read More
IGI Global Scientific Publishing expands ResearchGate partnership to full journal portfolio - April 2, 2025
IGI Global Scientific Publishing has expanded its partnership with ResearchGate, incorporating its entire journal portfolio into the Journal Home platform. With the addition of over 140 journals, the initiative now includes nearly 200 publications, enhancing visibility, accessibility, and engagement across a broad spectrum of… Read More
Springer Nature reports growth in open access and AI-powered publishing enhancements - April 1, 2025
Springer Nature has released its first annual report as a public company, outlining progress in open access publishing, AI-driven support for authors, and investments in research integrity. The report follows the company's strong financial performance announced on March 18, reinforcing its commitment to improving… Read More
STM joins EU rightsholders in rejecting third draft of GPAI Code of Practice - April 1, 2025
STM has joined a coalition of European authors, performers, publishers, and other rightsholders in opposing the third draft of the EU AI Act’s GPAI Code of Practice, citing significant concerns over its alignment with existing copyright law. The coalition argues that the current draft fails to uphold… Read More
Wiley releases 2025 edition of Mass Spectra of Designer Drugs for Forensic Laboratories - April 1, 2025
Wiley has announced the release of the Mass Spectra of Designer Drugs 2025, an essential resource for forensic laboratories worldwide. The annually updated database provides rapid identification of novel psychoactive substances (NPS), including fentanyl analogs, xylazine, synthetic cannabinoids, and other emerging opioids. This year’s edition expands the… Read More
F1000 expands Open Research Africa platform to all African-based authors - April 1, 2025
F1000 and the Science for Africa Foundation have announced a major expansion of Open Research Africa (ORA), removing funding restrictions for authors. Effective immediately, researchers based in Africa can submit articles to ORA regardless of their funding source, significantly broadening access… Read More
